TrialJapanese journal of clinical oncology2022

A randomized controlled trial evaluating the effect of low-dose chlormadinone in patients with low-risk prostate cancer: PROSAS study.

Mikio Sugimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.